Fluid flow induces COX-2 expression in MC3T3-E1 osteoblasts via a PKA signaling pathway

Biochemical and Biophysical Research Communications

Volumn 297, Issue 1, 2002, Pages 46-51

  Wadhwa, Sunil ^a   Choudhary, Shilpa ^b   Voznesensky, Maria ^b   Epstein, Mary ^b   Raisz, Lawrence ^b   Pilbeam, Carol ^b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Bone; Cyclooxygenase; Mechanical loading; Prostaglandins; Signal transduction

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOOXYGENASE 2; FORSKOLIN; LUCIFERASE; MESSENGER RNA; PROTEIN KINASE C;

ANIMAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FLUID FLOW; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHEAR STRESS; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLOOXYGENASE 2; ISOENZYMES; MICE; OSTEOBLASTS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SIGNAL TRANSDUCTION;

EID: 0036385945     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02124-1     Document Type: Conference Paper

References (33)

1. T.J. Chambers, S. Fox, C.J. Jagger, J.M. Lean, J.W. Chow, The role of prostaglandins and nitric oxide in the response of bone to mechanical forces, Osteoarthritis Cartilage 7 (1999) 422-423.
2. J.W. Chow, T.J. Chambers, Indomethacin has distinct early and late actions on bone formation induced by mechanical stimulation, Am. J. Physiol. 267 (1994) E287-E292.
3. M.J. Pead, L.E. Lanyon, Indomethacin modulation of load-related stimulation of new bone formation in vivo, Calcif. Tissue Int. 45 (1989) 34-40.
4. C.C. Pilbeam, J.R. Harrison, L.G. Raisz, Prostaglandins and bone metabolism, in: J.P. Bilezikian, L.G. Raisz, G.A. Rodan (Eds.), Principles of Bone Biology, Academic Press, New York, 2002, pp. 979-995.
5. M.R. Forwood, Inducible cyclo-oxygenase (COX-2) mediates the induction of bone formation by mechanical loading in vivo, J. Bone Miner. Res. 11 (1996) 1688-1693.
6. A. Ogasawara, T. Arakawa, T. Kaneda, T. Takuma, T. Sato, H. Kaneko, M. Kumegawa, Y. Hakeda, Fluid shear stress-induced cyclooxygenase-2 expression is mediated by β, CREB, and AP-1 in osteoblastic MC3T3-E1 cells, J. Biol. Chem. (2000).
7. 2+ regulates fluid shear-induced cytoskeletal reorganization and gene expression in osteoblasts, Am. J. Physiol. Cell. Physiol. 278 (2000) C989-C997.
8. K.M. Reich, J.A. Frangos, Effect of flow on prostaglandin E2 and inositol trisphosphate levels in osteoblasts, Am. J. Physiol. 261 (1991) C428-C432.
9. J. Klein-Nulend, E.H. Burger, C.M. Semeins, L.G. Raisz, C.C. Pilbeam, Pulsating fluid flow stimulates prostaglandin release and inducible prostaglandin G/H synthase mRNA expression in primary mouse bone cells, J. Bone Miner. Res. 12 (1997) 45-51.
10. S. Wadhwa, S.L. Godwin, D.R. Peterson, M.A. Epstein, L.G. Raisz, C.C. Pilbeam, Fluid flow induction of cyclo-oxygenase 2 gene expression in osteoblasts is dependent on an extracellular signal-regulated kinase signaling pathway, J. Bone Miner. Res. 17 (2002) 266-274.
11. H.L. Jessop, M. Sjoberg, M.Z. Cheng, G. Zaman, C.P. Wheeler-Jones, L.E. Lanyon, Mechanical strain and estrogen activate estrogen receptor α in bone cells, J. Bone Miner. Res. 16 (2001) 1045-1055.
12. O. Traub, B.P. Monia, N.M. Dean, B.C. Berk, PKC-epsilon is required for mechano-sensitive activation of ERK1/2 in endothelial cells, J. Biol. Chem. 272 (1997) 31251-31257.
13. K.M. Reich, J.A. Frangos, Protein kinase C mediates flow-induced prostaglandin E2 production in osteoblasts, Calcif. Tissue Int. 52 (1993) 62-66.
14. N.E. Ajubi, J. Klein-Nulend, M.J. Alblas, E.H. Burger, P.J. Nijweide, Signal transduction pathways involved in fluid flow-induced PGE2 production by cultured osteocytes, Am. J. Physiol. 276 (1999) E171-E178.
15. D.A. Kujubu, B.S. Fletcher, B.C. Varnum, R.W. Lim, H.R. Herschman, TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue, J. Biol. Chem. 266 (1991) 12866-12872.
16. N.G. Bazan, B.S. Fletcher, H.R. Herschman, P.K. Mukherjee, Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene, Proc. Natl. Acad. Sci. USA 91 (1994) 5252-5256.
17. D. Peterson, Development of a parallel plate flow chamber to study the fluid shear effects on living cells, Masters Thesis, University of Connecticut, 1995.
18. Y. Okada, O. Voznesensky, H. Herschman, J. Harrison, C. Pilbeam, Identification of multiple cis-acting elements mediating the induction of prostaglandin G/H synthase-2 by phorbol ester in murine osteoblastic cells, J. Cell. Biochem. 78 (2000) 197-209.
19. C. Pilbeam, Y. Rao, O. Voznesensky, H. Kawaguchi, C. Alander, L. Raisz, H. Herschman:, Transforming growth factor-β1 regulation of prostaglandin G/H synthase-2 expression in osteoblastic MC3T3-E1 cells, Endocrinology 138 (1997) 4672-4682.
20. D. Toullec, P. Pianetti, H. Coste, P. Bellevergue, T. Grand-Perret, M. Ajakane, V. Baudet, P. Boissin, E. Boursier, F. Loriolle, et al., The bisindolylmaleimide GF109203X is a potent and selective inhibitor od protein kinase, J. Biol. Chem. 266 (1991) 15771-15781.
21. T.E. Harris, S.J. Persaud, P.M. Jones, Pseudosubstrate inhibition of cyclic AMP-dependent protein kinase in intact pancreatic islets: effects on cyclic AMP-dependent and glucose-dependent insulin secretion, Biochem. Biophys. Res. Commun. 232 (1997) 648-651.
22. T. Chijiwa, A. Mishima, M. Hagiwara, M. Sano, K. Hayashi, T. Inoue, K. Naito, T. Toshioka, H. Hidaka, Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquino-linesulfonamide (H-89), of PC12D pheochromocytoma cells, J. Biol. Chem. 265 (1990) 5267-5272.
23. J.S. Nixon, S.E. Wilkinson, P.D. Davis, A.D. Sedgwick, J. Wadsworth, D. Westmacott, Modulation of cellular processes by H7, a non-selective inhibitor of protein kinases, Agents Actions 32(1991) 188-193.
24. J. Quick, J.A. Ware, P.E. Driedger, The structure and biological activities of the widely used protein kinase inhibitor, H7, differ depending on the commercial source, Biochem. Biophys. Res. Commun. 187 (1992) 657-663.
25. K.M. Reich, C.V. Gay, J.A. Frangos, Fluid shear stress as a mediator of osteoblast cyclic adenosine monophosphate production, J. Cell. Physiol. 143 (1990) 100-104.
26. C.C. Pilbeam, L.G. Raisz, O. Voznesensky, C.B. Alander, B.N. Delman, H. Kawaguchi, Autoregulation of inducible prostaglan-din G/H synthase in osteoblastic cells by prostaglandins, J. Bone Miner. Res. 10 (1995) 406-414.
27. J. Wu, P. Dent, T. Jelinek, A. Wolfman, M.J. Weber, T.W. Sturgill, Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate, Science 262 (1993) 1065-1069.
28. M.R. Vossler, H. Yao, R.D. York, M.G. Pan, C.S. Rim, P.J. Stork, cAMP activates MAP kinase and Elk-1 through a B-Raf-and Rap1-dependent pathway, Cell 89 (1997) 73-82.
29. M.H. Verheijen, L.H. Defize, Parathyroid hormone inhibits mitogen-activated protein kinase activation in osteosarcoma cells via a protein kinase A-dependent pathway, Endocrinology 136 (1995) 3331-3337.
30. S.R. Siddhanti, J.E. Hartle, 2nd, L.D. Quarles, Forskolin inhibits protein kinase C-induced mitogen activated protein kinase activity in MC3T3-E1 osteoblasts, Endocrinology 136 (1995) 4834-4841.
31. L.R. Chaudhary, L.V. Avioli, Identification and activation of mitogen-activated protein (MAP) kinase in normal human osteoblastic and bone marrow stromal cells: attenuation of MAP kinase activation by cAMP, parathyroid hormone and forskolin, Mol. Cell. Biochem. 178 (1998) 59-68.
32. R.A. Hipskind, G. Bilbe, MAP kinase signaling cascades and gene expression in osteoblasts, Front Biosci. 3 (1998) D804-D816.
33. D.R. Tyson, J.T. Swarthout, N.C. Partridge, Increased osteo-blastic c-fos expression by parathyroid hormone requires protein kinase A phosphorylation of the cyclic adenosine 3′,5′-monophosphate response element-binding protein at serine 133, Endocrinology 140 (1999) 1255-1261.